Literature DB >> 12582814

Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study.

Sofiane Maza1, Ray Valencia, Lilli Geworski, Dirk Sandrock, Andreas Zander, Heike Audring, Erik Dräger, Helmut Winter, Wolfram Sterry, Dieter L Munz.   

Abstract

The concept of sentinel lymph node biopsy in cutaneous malignant melanoma is widely established. Preoperative cutaneous lymphoscintigraphic mapping is a reliable method for identifying the nodal basins at risk of metastases in melanomas. In this prospective study we investigated the correlation between the scintigraphic appearance time and the metastatic involvement of sentinel lymph nodes. In 276 malignant melanoma patients (137 women, 139 men; age 16-93 years), dynamic and static lymphoscintigraphy was performed after strict intracutaneous application of technetium-99m nanocolloid (40-150 MBq; 0.05 ml/deposit) around the tumour or biopsy scar. Analysis of dynamic scans primarily focussed on the appearance time of sentinel lymph nodes. Sentinel lymph node visualisation </=20 min post injection was defined as fast drainage, and visualisation >20 min as slow drainage. Fast lymphatic drainage was found in 236 patients, of whom 34 (14.4%) had sentinel lymph node metastases. Twenty-two patients showed hybrid (fast and slow) lymphatic drainage, and eight (36.4%) of them had sentinel lymph node metastases. Seven of the latter demonstrated fast lymphatic drainage, while one showed one positive sentinel lymph node with fast and another with slow drainage. The melanomas of 18 patients demonstrated exclusively slow lymphatic drainage, in all cases without sentinel lymph node metastases. This prospective study indicates that the scintigraphic appearance time of sentinel lymph nodes seems to be a clinically relevant factor for prediction of metastatic spread of cutaneous malignant melanoma. Larger numbers of patients need to be examined to truly assess the benefit of the scintigraphic appearance time compared with other predictors of sentinel lymph node tumour positivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582814     DOI: 10.1007/s00259-003-1114-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  22 in total

Review 1.  Nuclear medicine and the surgeon.

Authors:  D Krag; F Moffat
Journal:  Lancet       Date:  1999-09-18       Impact factor: 79.321

2.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.

Authors:  P I Haigh; N M Hansen; A E Giuliano; G K Edwards; W Ye; E C Glass
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

3.  Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe.

Authors:  A Mudun; D R Murray; S C Herda; D Eshima; L A Shattuck; J P Vansant; A T Taylor; N P Alazraki
Journal:  Radiology       Date:  1996-04       Impact factor: 11.105

4.  The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

Authors:  M G Statius Muller; P A van Leeuwen; E S de Lange-De Klerk; P J van Diest; R Pijpers; C C Ferwerda; R J Vuylsteke; S Meijer
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

5.  Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.

Authors:  J F Thompson; W H McCarthy; C M Bosch; C J O'Brien; M J Quinn; S Paramaesvaran; K Crotty; S W McCarthy; R F Uren; R Howman-Giles
Journal:  Melanoma Res       Date:  1995-08       Impact factor: 3.599

6.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

Review 7.  Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.

Authors:  K M McMasters; D S Reintgen; M I Ross; J E Gershenwald; M J Edwards; A Sober; N Fenske; F Glass; C M Balch; D G Coit
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

8.  Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma.

Authors:  R F Uren; R Howman-Giles; J F Thompson; H M Shaw; M J Quinn; C J O'Brien; W H McCarthy
Journal:  Melanoma Res       Date:  1994-12       Impact factor: 3.599

9.  Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.

Authors:  J J Albertini; C W Cruse; D Rapaport; K Wells; M Ross; R DeConti; C G Berman; K Jared; J Messina; G Lyman; F Glass; N Fenske; D S Reintgen
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

10.  The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study.

Authors:  H J Fee; D S Robinson; W F Sample; L S Graham; E C Holmes; D L Morton
Journal:  Surgery       Date:  1978-11       Impact factor: 3.982

View more
  9 in total

1.  Precise localisation of a sentinel lymph node in a rare drainage region with SPECT/MRI using interstitial injection of 99mTc-nanocolloid and superparamagnetic iron oxide.

Authors:  Sofiane Maza; Matthias Taupitz; Thorsten Wegner; Matthias Muehler; Andreas Zander; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02       Impact factor: 9.236

Review 2.  Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature.

Authors:  Sofiane Maza; Uwe Trefzer; Maja Hofmann; Silke Schneider; Christiane Voit; Thomas Krössin; Andreas Zander; Heike Audring; Wolfram Sterry; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-24       Impact factor: 9.236

3.  The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Authors:  Lutz Kretschmer; Hans Peter Bertsch; Pawel Bardzik; Johannes Meller; Simin Hellriegel; Kai-Martin Thoms; Michael Peter Schön; Carsten Oliver Sahlmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-15       Impact factor: 9.236

4.  Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entities.

Authors:  Sofiane Maza; Mathias Taupitz; Kasra Taymoorian; Klaus Jürgen Winzer; Jens Rückert; Christian Paschen; Gert Räber; Sylke Schneider; Uwe Trefzer; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-11       Impact factor: 9.236

5.  Does increased lymphatic density contribute to fast drainage and metastatic spread to sentinel lymph nodes in melanoma?

Authors:  D L Munz
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

6.  Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities.

Authors:  Hiroyuki Miura; Shuichi Ono; Koichi Shibutani; Hiroko Seino; Fumiyasu Tsushima; Shinya Kakehata; Katsumi Hirose; Hiromasa Fujita; Akihisa Kakuta; Masahiko Aoki; Yoshiomi Hatayma; Hideo Kawaguchi; Mariko Sato; Yoshihiro Takai; Takahide Kaneko; Daisuke Sawamura
Journal:  Springerplus       Date:  2014-10-22

Review 7.  Tumor Regulation of Lymph Node Lymphatic Sinus Growth and Lymph Flow in Mice and in Humans.

Authors:  Lauren M Habenicht; Sara B Kirschbaum; Momoko Furuya; Maria I Harrell; Alanna Ruddell
Journal:  Yale J Biol Med       Date:  2017-09-25

Review 8.  Dissecting the Lymphatic System to Predict Melanoma Metastasis.

Authors:  Rishi Suresh; Arturas Ziemys; Ashley M Holder
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

9.  Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles.

Authors:  S C Partridge; B F Kurland; C-L Liu; R J Y Ho; A Ruddell
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.